搜索临床试验以:CDK inhibitor
总计65416个结果
-
Singh, Ranjan Kumar, M.D.完全的
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.The First People's Hospital of Hefei; Hefei Binhu Hospital未知急性髓性白血病 | 血管免疫母细胞性T细胞淋巴瘤 | 肝脾T细胞淋巴瘤 | 前体 T 细胞淋巴细胞白血病-淋巴瘤 | 结外 NK/T 细胞淋巴瘤,鼻型 | T 细胞幼淋巴细胞白血病 | T 细胞大颗粒淋巴细胞白血病 | 外周 T 细胞淋巴瘤,NOS | 肠病型肠T细胞淋巴瘤中国
-
Chong Kun Dang Pharmaceutical尚未招聘
-
University Hospital HeidelbergAmsterdam Institute for Global Health and Development; Swiss Tropical & Public Health Institute 和其他合作者招聘中
-
Seoul National University HospitalEnsol Biosciences, Inc.完全的
-
St. Antonius HospitalMaasstad Hospital完全的
-
Xuanwu Hospital, BeijingBaoding Children's Hospital招聘中
-
Hilary L Surratt, PhDNational Institute on Drug Abuse (NIDA)主动,不招人
-
Electrochemical Oxygen Concepts, Inc.完全的
-
Chong Kun Dang Pharmaceutical完全的
-
University of RochesterNational Institutes of Health (NIH)尚未招聘
-
HealthPartners InstituteNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
Abdul Latif Jameel Poverty Action LabIcahn School of Medicine at Mount Sinai终止
-
Kaiser PermanenteUniversity of California, San Francisco; OCHIN, Inc.主动,不招人
-
National Institute of Allergy and Infectious Diseases...Genentech, Inc.完全的